Skip to main content

Table 4 Baseline LDL cholesterol levels modelled as 'untreated' (see text for methods)

From: Patterns and predictors of statin prescription in patients with type 2 diabetes

LDL cholesterol (mg/dl) Primary prevention    Secondary prevention   
  Percent statin use Odds ratio (95% CI) P-value Percent statin use (%) Odds ratio (95% CI) P-value
   <100 12.6%
(11.4 to 13.9)
referent   39.0%
(36.9 to 41.2)
referent  
   ≥100 and <130 14.8%
(14.0 to 15.7)
1.20
(1.06 to 1.37)
0.005 38.2%
(36.6 to 39.7)
0.97
(0.87 to 1.08)
0.54
   ≥130 and <160 16.2%
(15.4 to 17.1)
1.34
(1.18 to 1.52)
<0.0001 34.4%
(32.9 to 35.8)
0.82
(0.74 to 0.92)
0.0004
   ≥160 28.5%
(27.5 to 29.5)
2.76
(2.45 to 3.11)
<0.0001 43.3%
(41.9 to 44.7)
1.20
(1.08 to 1.33)
0.0009
  1. *Proportions are described as percent and 95% confidence intervals for binomial distributions. Odds ratios with 95% confidence intervals were estimated by logistic regression analysis without adjustments.